Stock KHRN.H KHIRON LIFE SCIENCES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Khiron Life Sciences Corp.

Equities

KHRN.H

CA49374L3065

Pharmaceuticals

Delayed Toronto S.E.
Other stock markets
 08:24:46 05/05/2023 pm IST 		5-day change 1st Jan Change
0.04 CAD -.--% Intraday chart for Khiron Life Sciences Corp. -.--% -.--%
2023 Colombia's cannabis industry in crisis over regulatory, political hurdles RE
2023 2518542 Alberta Ltd completed the acquisition of Khiron Europe Gmbh, Zerenia Clinics Limited, Khiron Life Sciences Spain SL, Khiron Life Sciences Uk and Pharmadrug Production GmbH from Khiron Life Sciences Corp.. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021
Capitalization 1 114.8 123.6 56.52 37.61
Enterprise Value (EV) 1 98.36 90.43 51.14 30.92
P/E ratio -3.75 x -2.94 x -1.88 x -1.04 x
Yield - - - -
Capitalization / Revenue 12,87,63,858 x 1,28,99,638 x 70,49,882 x 29,39,788 x
EV / Revenue 11,03,10,331 x 94,37,264 x 63,78,653 x 24,16,458 x
EV / EBITDA -5.16 x -2.55 x -2.23 x -1.57 x
EV / FCF -91,94,762 x -44,53,326 x -16,03,266 x -26,92,729 x
FCF Yield -0% -0% -0% -0%
Price to Book 4.5 x 1.76 x 0.89 x 1.13 x
Nbr of stocks (in thousands) 75,043 1,16,612 1,50,717 1,79,117
Reference price 2 1.530 1.060 0.3750 0.2100
Announcement Date 30/04/19 01/05/20 29/04/21 29/04/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021
Net sales - 0.8917 9.582 8.017 12.8
EBITDA 1 -4.517 -19.04 -35.48 -22.98 -19.72
EBIT 1 -4.518 -19.38 -35.98 -23.6 -20.52
Operating Margin - -2,172.89% -375.48% -294.44% -160.4%
Earnings before Tax (EBT) 1 -4.535 -19.73 -36.36 -23.95 -33.59
Net income 1 -4.535 -19.81 -36.38 -24.04 -33.13
Net margin - -2,221.27% -379.63% -299.85% -258.92%
EPS 2 -0.1634 -0.4082 -0.3600 -0.2000 -0.2014
Free Cash Flow - -10.7 -20.31 -31.9 -11.48
FCF margin - -1,199.71% -211.91% -397.85% -89.74%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 15/05/18 30/04/19 01/05/20 29/04/21 29/04/22
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales 1 1.67 1.928 2.518 2.837 2.803 3.519 3.636 4.643 4.473 3.385
EBITDA 1 -3.855 -4.706 -5.805 -4.019 -3.85 -3.772 -5.649 -3.057 -2.288 -2.831
EBIT - - - - - - - - - -
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS - - - - - - - - - -
Dividend per Share - - - - - - - - - -
Announcement Date 24/08/20 30/11/20 29/04/21 27/05/21 23/08/21 22/11/21 29/04/22 30/05/22 26/08/22 30/11/22
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021
Net Debt 1 - - - - -
Net Cash position 1 1.81 16.5 33.2 5.38 6.7
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -10.7 -20.3 -31.9 -11.5
ROE (net income / shareholders' equity) - -143% -76.1% -36.1% -68.6%
ROA (Net income/ Total Assets) - -56% -36.8% -19% -22.2%
Assets 1 - 35.37 98.89 126.4 149.1
Book Value Per Share 2 0.0700 0.3400 0.6000 0.4200 0.1900
Cash Flow per Share 2 0.0600 0.2000 0.0800 0.0500 0.0500
Capex 1 0.29 3.83 6.09 2.69 1.74
Capex / Sales - 429.06% 63.6% 33.59% 13.63%
Announcement Date 15/05/18 30/04/19 01/05/20 29/04/21 29/04/22
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
KHIRON LIFE SCIENCES CORP. Stock Khiron Life Sciences Corp.
-.--% 6.81M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.96% 6.32B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.56% 4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.52% 3.3B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+5.47% 3.19B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.76% 2.6B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+56.34% 2.05B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.11% 1.77B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+2.93% 1.7B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.02% 1.63B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. KHRN.H Stock
  4. Financials Khiron Life Sciences Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW